Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Market Volatility | Centene faces challenges in ACA Marketplace and Medicaid, withdrawing 2025 guidance amid rising healthcare costs and regulatory uncertainties |
Strategic Positioning | Explore Centene's diversified portfolio across government-sponsored healthcare programs and its potential for growth in Medicare Advantage |
Financial Outlook | Analysts revise price targets, ranging from $30 to $90, reflecting varied perspectives on Centene's profitability and growth potential |
Competitive Edge | Delve into Centene's market leadership in Medicaid managed care and its strategies to navigate industry-wide challenges in risk pool management |
Metrics to compare | CNC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCNCPeersSector | |
---|---|---|---|---|
P/E Ratio | 8.5x | 5.4x | −0.7x | |
PEG Ratio | −0.39 | 0.03 | 0.00 | |
Price/Book | 0.6x | 1.6x | 2.6x | |
Price / LTM Sales | 0.1x | 0.9x | 3.3x | |
Upside (Analyst Target) | −4.0% | 12.2% | 39.6% | |
Fair Value Upside | Unlock | 3.9% | 6.0% | Unlock |